Title : Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer.

Pub. Date : 2017 Aug

PMID : 28654865






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Of the two phosphatidylcholine-specific PLD enzymes, only PLD1, but not PLD2, mRNA was down-regulated by doxorubicin treatment. Doxorubicin phospholipase D1 Homo sapiens
2 PLD1 and ChKalpha protein levels decreased following doxorubicin treatment in a concentration dependent manner. Doxorubicin phospholipase D1 Homo sapiens
3 Treatment with the PLD1 specific inhibitor VU0155069 sensitized MCF7 and MDA-MB-231 breast cancer cells to doxorubicin-induced cytotoxicity. Doxorubicin phospholipase D1 Homo sapiens
4 Doxorubicin induced GPC increase and PC decrease are caused by reductions in PLD1, GDPD6, and ChKalpha mRNA and protein expression. Doxorubicin phospholipase D1 Homo sapiens